$RTX Corp(RTX.US)$ i’m wondering how high this is going to go on Monday? i’m thinking 3% to 5% next week.

$Legend Biotech(LEGN.US)$ $Johnson & Johnson(JNJ.US)$
🔔 FDA approves CARVYKTI® label expansion 🎉
⇨ 1st and only BCMA-targeted CAR-T cell therapy
for 2nd-line Tx of multiple myeloma
⇨ based on CARTITUDE-4 study
⇨ 11:0 favorable FDA AdCom votes

🗓️ Last week’s PDUFAs:
$Akebia Therapeutics(AKBA.US)$ : Approved 🎉
⇒ Vafseo (Vadadustat)
⇒ Anemia due to CKD
⇒ NDA
⇒ PDUFA: 3/27/24
$Merck & Co(MRK.US)$ : Approved 🎉
⇒ WINREVAIR (sotatercept)
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24
$AstraZeneca(AZN.US)$ : Approved 🎉
⇒ Ultomiris (ravulizumab)
⇒ NMOSD
⇒ sBLA
$Regeneron Pharmaceuticals(REGN.US)$ : CRL 🙁
⇒ Odronextamab
⇒ r/r FL and r/r DLBCL
⇒ BLA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs: 🚨
$AstraZeneca(AZN.US)$ : 🤔
⇒...

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx(ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics(ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics(BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals(CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals(DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics(FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals(FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Vanda Pharmaceuticals(VNDA.US)$ $Legend Biotech(LEGN.US)$ $Supernus Pharmaceuticals(SUPN.US)$ $ImmunityBio(IBRX.US)$ $Aquestive Therapeutics(AQST.US)$ $X4 Pharmaceuticals(XFOR.US)$ $Liquidia(LQDA.US)$ $Neurocrine Biosciences(NBIX.US)$ $Moderna(MRNA.US)$ $Day One Biopharmaceuticals(DAWN.US)$
...

$Vanda Pharmaceuticals(VNDA.US)$ PDUFA
$Intra-Cellular Therapies(ITCI.US)$ Phase 3
$Bristol-Myers Squibb(BMY.US)$ PDUFA
$Alzamend Neuro(ALZN.US)$ Phase 2
$Alzamend Neuro(ALZN.US)$ Phase 2a

Several highly anticipated PDUFA decisions are approaching..👇
Abeona Therapeutics ( $Abeona Therapeutics(ABEO.US)$ )
Asset: Pz-cel (prademagene zamikeracel)
PDUFA Date: May 25, 2024
Indication: Recessive dystrophic epidermolysis bullosa (RDEB)
Technology: Autologous cell therapy, treatment uses gene transfer to deliver COL7A1 genes into an RDEB patient’s own skin cells then transplanting them back to the patient.
Rocket Pharmaceuticals ( $Rocket Pharmaceuticals(RCKT.US)$ )...

🗓️ Last week’s PDUFAs:
$Orchard Therapeutics(ORTX.US)$ (Kyowa Kirin): Approved 🎉
⇒ Lenmeldy (atidarsagene autotemcel)
⇒ early-onset MLD
⇒ BLA
⇒ PDUFA: 3/18/24
$Esperion Therapeutics(ESPR.US)$ : Approved 🎉
⇒ Nexletol (bempedoic acid) & Nexlizet (bempedoic acid and ezetimibe)
⇒ CV risk reduction, primary hyperlipidemia (HeFH)
⇒ sNDA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs:
$Merck & Co(MRK.US)$ : 🤔
⇒ Sotatercept
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24...

$MINISO(MNSO.US)$  five below, dollar general, dollar tree, hasbro,  mattel toy killer. reported great earnings !
$Walmart(WMT.US)$ $Five Below(FIVE.US)$ $Dollar General(DG.US)$ $Dollar Tree(DLTR.US)$ $Hasbro(HAS.US)$ $Mattel(MAT.US)$